| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.58B | 33.86B | 32.41B | 36.81B | 34.30B | 30.89B |
| Gross Profit | 10.97B | 11.44B | 14.50B | 18.45B | 14.95B | 13.39B |
| EBITDA | 5.01B | 4.54B | 9.47B | 6.99B | 10.11B | 9.26B |
| Net Income | 4.28B | 2.96B | 6.35B | 4.63B | 6.89B | 6.33B |
Balance Sheet | ||||||
| Total Assets | 77.08B | 86.15B | 81.44B | 78.49B | 82.92B | 64.67B |
| Cash, Cash Equivalents and Short-Term Investments | 27.78B | 31.44B | 32.53B | 33.05B | 34.92B | 32.27B |
| Total Debt | 4.83B | 415.79M | 5.06B | 411.08M | 418.89M | 487.31M |
| Total Liabilities | 24.34B | 28.54B | 22.44B | 21.57B | 30.76B | 18.59B |
| Stockholders Equity | 52.57B | 57.38B | 58.69B | 56.32B | 52.14B | 46.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.54B | 1.93B | 12.81M | 4.16B | 9.72B |
| Operating Cash Flow | 0.00 | 8.53B | 5.05B | 3.18B | 8.56B | 10.69B |
| Investing Cash Flow | 0.00 | 256.71M | -7.70B | -3.60B | -4.40B | 375.57M |
| Financing Cash Flow | 0.00 | -6.26B | -3.81B | -2.21B | -2.17B | -2.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥133.17B | 17.51 | ― | 3.24% | 18.70% | 33.93% | |
76 Outperform | ¥62.19B | 14.88 | ― | 2.79% | 2.85% | 3.17% | |
73 Outperform | ¥139.42B | 12.20 | ― | 2.86% | 89.90% | 190.48% | |
72 Outperform | ¥102.32B | 28.54 | ― | 2.16% | -8.71% | -17.77% | |
70 Outperform | ¥70.88B | 14.83 | ― | 3.09% | 6.35% | -34.20% | |
66 Neutral | ¥150.55B | 46.25 | ― | 2.72% | -6.46% | -47.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Optorun Co., Ltd. plans to replace its current accounting auditor, Taiyu Audit LLC, with Moore Mirai & Co., subject to approval at the 27th ordinary general shareholders’ meeting on March 26, 2026. The company judged Moore Mirai & Co. to be better suited to its future business development, citing expertise, independence, quality control systems and audit fees, as well as the need to respond more effectively to expanding international operations.
The term of Taiyu Audit LLC will end at the close of the shareholders’ meeting, and there were no adverse comments or issues flagged in audit reports over the past three years. Both the outgoing auditor and Optorun’s audit and supervisory board raised no objections to the change, underscoring that the move is a proactive governance step rather than a reaction to audit concerns, and signaling strengthened oversight as the company pursues global growth.
The most recent analyst rating on (JP:6235) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on OPTORUN CO.,LTD. stock, see the JP:6235 Stock Forecast page.
Optorun Co., Ltd. has announced a reshuffle of its leadership team, highlighted by the resignation of Daiyu Son from executive duties while retaining the title of honorary chairman, and the retirement of senior advisor Toshinori Takahashi, advisor Hideyuki Odagi and director Koji Kondo. The changes, slated to take effect following shareholder approval on March 26, 2026, are paired with the reappointment of Chairman of the Board Ihei Hayashi, Representative Director and President/CEO Bin Fan, and three outside directors, suggesting continuity in core management and oversight alongside a generational transition in advisory roles.
The updated executive structure will also maintain a mix of internal and external oversight through Audit & Supervisory Board Member Masahi Awaji and outside members Hironobu Sasada and Ritsu Katayama, reinforcing established governance practices. For stakeholders, the combination of retiring long‑serving advisors and reappointing key board figures signals an attempt to balance leadership renewal with stability, which may support strategic consistency while gradually refreshing the company’s decision‑making base.
The most recent analyst rating on (JP:6235) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on OPTORUN CO.,LTD. stock, see the JP:6235 Stock Forecast page.
Optorun outlined its consolidated results for fiscal 2025 and issued guidance for 2026, emphasizing its vulnerability to foreign exchange swings due to dollar-denominated exports and yuan-linked manufacturing costs. To mitigate FX and geopolitical risks while supporting global demand, the company plans to expand production and development sites across Japan, China, Vietnam, India, and other regions, underpinned by exchange-rate assumptions of ¥148 per U.S. dollar and ¥22 per Chinese yuan.
Marking its 25th anniversary, Optorun announced a “second founding” phase focused on stabilizing its deposition product business and deepening partnerships as it advances into higher-value optical solutions. Management set mid-term goals of a net profit margin of at least 15%, ROE of 10% or higher, and a dividend payout ratio of 30% or more, with capital allocation prioritizing stable dividends, flexible share buybacks, and strategic investments in R&D, capex, and M&A to enhance shareholder value and sustain growth.
The most recent analyst rating on (JP:6235) stock is a Hold with a Yen2245.00 price target. To see the full list of analyst forecasts on OPTORUN CO.,LTD. stock, see the JP:6235 Stock Forecast page.
Optorun reported consolidated results for the fiscal year ended December 31, 2025, with net sales rising 4.5% year on year to ¥33.9 billion but profitability weakening sharply. Operating profit fell 49.2% to ¥3.3 billion, ordinary profit dropped 60.9% to ¥3.2 billion, and profit attributable to owners of parent slumped 53.4% to ¥3.0 billion, reflecting margin pressure and a swing from positive to negative equity-method contributions.
Despite higher total assets and a solid equity ratio of 66.6%, equity and net assets both declined versus the prior year, while return on equity halved to 5.1% and the operating margin slid to 9.8%. The company maintained an aggressive shareholder-return stance, lifting the annual dividend to ¥54 per share for 2025, implying a payout ratio of 73.7%, and it forecasts a rebound in 2026 with net sales up 12.8% and profit nearly doubling, supported by stronger operating leverage and expected recovery in ordinary profit.
Cash flows from operating activities improved markedly to ¥8.5 billion and cash and equivalents increased to ¥31.4 billion, even as financing cash flows were negative due to shareholder returns and other outflows. The company also expanded its treasury stock holdings materially, reducing the average number of shares outstanding and supporting earnings per share dynamics despite lower absolute profit.
The most recent analyst rating on (JP:6235) stock is a Hold with a Yen2245.00 price target. To see the full list of analyst forecasts on OPTORUN CO.,LTD. stock, see the JP:6235 Stock Forecast page.
Optorun is transitioning from a manufacturer of optical thin-film deposition equipment to a broader optical thin-film deposition company, leveraging its 25-year foundation in precision manufacturing technologies. The company’s operations are highly export-oriented, with key exposure to U.S. dollar-denominated sales and Chinese yuan-linked production costs, as it scales its footprint across Asia to tap expanding global demand.
In its latest update on consolidated results and guidance, Optorun outlined measures to meet new Tokyo Stock Price Index criteria, underscoring the importance of liquidity and free-float market capitalization for continued index inclusion. Management set mid-term targets including a net profit margin of at least 15%, ROE of 10% or higher, and a consolidated dividend payout ratio of 30% or more, while signaling a capital allocation policy centered on stable dividends, flexible share buybacks, and sustained investment in R&D, capex, and M&A to support long-term growth.
The company highlighted its sensitivity to currency movements and based its FY2026 outlook on exchange rate assumptions of 148 yen to the U.S. dollar and 22 yen to the Chinese yuan, quantifying the profit impact of yen appreciation against both currencies. Alongside geographic diversification of production in Japan, China, Vietnam, and India to mitigate tariff and FX risks, these financial and operational commitments suggest a push to improve both shareholder value and resilience in a shifting macro and market environment.
The most recent analyst rating on (JP:6235) stock is a Hold with a Yen2245.00 price target. To see the full list of analyst forecasts on OPTORUN CO.,LTD. stock, see the JP:6235 Stock Forecast page.
Optorun reported a modest 4.5% rise in net sales to ¥33.86 billion for the fiscal year ended Dec. 31, 2025, but profitability weakened sharply, with operating profit down 49.2% and profit attributable to owners of the parent dropping 53.4%. Margins and returns deteriorated, as seen in the operating margin falling to 9.8% and return on equity sliding to 5.1%, while equity ratio also declined despite total assets increasing.
The company maintained an aggressive shareholder-return stance, raising the annual dividend to ¥54 per share for 2025, up from ¥52, lifting the payout ratio to 73.7% even as earnings fell. For fiscal 2026, Optorun forecasts a 12.8% increase in net sales and a near-doubling of operating profit, signaling expectations of a rebound in demand or improved profitability, and it plans a further dividend hike to ¥56 per share, underscoring management’s confidence but also increasing pressure to deliver the projected earnings recovery.
The most recent analyst rating on (JP:6235) stock is a Hold with a Yen2245.00 price target. To see the full list of analyst forecasts on OPTORUN CO.,LTD. stock, see the JP:6235 Stock Forecast page.
Optorun Co., Ltd. has announced a reshuffle of its executive leadership, elevating Jianzheng Xi from managing executive officer to senior executive officer while executive officer in charge of accounting, Koji Kondo, is retiring. The company is also formalizing and strengthening its regional management structure by appointing Lei Rong as executive officer alongside their roles as general manager of Optorun Semiconductor System Corporation and CEO of Optorun USA, Inc., and naming Zhifei Huang as an executive officer while continuing as general manager of OPTORUN (SHANGHAI) CO., LTD., moves that appear aimed at tightening oversight and coordination across its U.S. and Chinese operations.
The most recent analyst rating on (JP:6235) stock is a Hold with a Yen2207.00 price target. To see the full list of analyst forecasts on OPTORUN CO.,LTD. stock, see the JP:6235 Stock Forecast page.
Optorun Co., Ltd. has approved the disposal of 2,256 shares of its treasury stock as restricted stock to 12 employees and officers of its subsidiaries, with a total disposal value of approximately ¥4.39 million and a per-share price of ¥1,947, to be paid in via monetary claims on January 30, 2025. The program is designed as a long-term incentive scheme to align key personnel with the company’s performance and corporate value growth, with allocation based on job function, achievement of sales and operating profit targets, performance evaluations, and years of service, and includes transfer restrictions of three and five years to promote retention and sustained contribution across the group.
The most recent analyst rating on (JP:6235) stock is a Hold with a Yen1938.00 price target. To see the full list of analyst forecasts on OPTORUN CO.,LTD. stock, see the JP:6235 Stock Forecast page.